Adult Clinical Oral Nutrition Market Size & Share 2023 to 2032
Market Size by Product Type (Milk Based Products, Fruit Drinks, Desserts, Savory Products), by Therapeutic Area (Malnutrition, Dysphagia, Glycemia, Cancer, Gastrointestinal Disorders), by Form (Powder, Liquid), Sales Channel & Forecast.
Report ID: GMI5424
|
Published Date: February 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Adult Clinical Oral Nutrition Market Size
Adult Clinical Oral Nutrition Market size crossed USD 8 billion in 2022 and is poised to depict over 5% CAGR through 2023-2032, on account of the growing burden of chronic diseases.
Adult Clinical Oral Nutrition Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
With the mounting prevalence of non-communicable diseases such as malnutrition and obesity, the rate of prolonged hospitalization is increasing globally. Based on study data from Baxter International, approximately 2 million hospital stays involve malnutrition in the U.S. Such factors will boost the acceptance of oral nutritional therapy as a safe and effective way to fight adult malnutrition. Likewise, the burden of chronic and metabolic disorders has risen across the globe, further increasing demand for the therapy.
Additionally, according to the International Diabetes Federation, in 2021, over 537 million adults were diagnosed with diabetes in middle- and low-income countries. The requirement for malnutrition management among hospitalized patients with diabetes will therefore surge and in turn, strengthen the industry outlook. However, the introduction of stringent regulatory frameworks associated with product efficacy and labeling may restrict the development of adult oral nutrition support solutions to some extent over the forecast period.
Adult Clinical Oral Nutrition Market Analysis
Adult clinical oral nutrition market value from the milk-based product segment is expected to surpass USD 6.5 billion by 2032, given the high concentration of calcium, potassium, and other nutrients. In addition, milk-based clinical nutrition has emerged as an efficient dietary option for obesity treatment in adult patients. According to the U.S. Dairy Export Council, these dairy proteins consist of several nutrients required to treat cancer and gastrointestinal diseases, in turn contributing to product consumption across the healthcare sector.
Based on the therapeutic area, the adult clinical oral nutrition market size from the malnutrition segment is set to be valued at more than USD 4 billion by 2032. The increasing knowledge about the benefits of varied oral nutrition types in the precise management of nutrient imbalance or impaired nutrient utilization is a major growth driver for the adult clinical oral nutrition industry. Such factors will augment the need for efficient nutritional supplements to boost immunity and consequently, create lucrative opportunities for adult oral clinical nutrition product development.
Adult clinical oral nutrition market from the liquid form segment will be worth over USD 5.5 billion by 2032, due to the growing cases of protein deficiency. Based on estimates from the Annals of the New York Academy of Sciences, almost 1 billion people across the globe have inadequate protein intake. As a result, the consumption of ready-to-drink protein supplements is like to rise. Furthermore, liquid supplements are gaining massive momentum among patients who have undergone major surgeries. The introduction of surgical quality improvement programs in hospitals will therefore boost the intake of liquid nutritional supplements.
The brick-and-mortar sales channel segment accounted for a substantial share of the adult clinical oral nutrition market in 2022, given the better inventory options and no shipping costs, among other benefits. The introduction of pharmacy chain expansion projects has also increased in emerging nations. For example, in January 2023, Reliance Retail unveiled plans to open over 2,000 standalone pharmacy stores within one year. Such initiatives, alongside the delivery of personalized nutrition plans by in-store dietitians, will encourage patients to opt for clinical oral nutrition therapies from brick-and-mortar stores.
Europe adult clinical oral nutrition market share is projected to depict over 4.5% CAGR through 2032, driven by the rising adoption of sedentary lifestyle and the high malnutrition prevalence. As per statistics from Health Europa, almost 1 in 10 older adults aged 65 years or above are malnourished or at risk of malnutrition in the UK. Furthermore, with the escalating number of geriatric patients suffering from intestinal obstruction and other gastrointestinal disorders, the intake of clinical oral nutrition solutions will grow in the region.
Adult Clinical Oral Nutrition Market Share
are some of the key players in the market. Mergers and acquisitions are among the key strategies being employed by these companies to expand their presence in the global market.
Impact of COVID-19 pandemic
Malnutrition has become an imminent urban challenge and was further intensified by the COVID-19 outbreak. This growing burden of malnutrition is mainly due to the rising food prices and the declining income in the aftermath of the pandemic. In middle- and low-income countries, for example, COVID-19-induced food insecurity has significantly impacted the urban poor population. Factors such as these will boost awareness about the benefits of clinical oral nutrition among adults and subsequently strengthen the industry outlook over the estimated timeline.
Adult clinical oral nutrition market research report includes in-depth coverage of the industry with estimates & forecast in terms of USD Million from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Product
By Therapeutic Area
By Form
By Sales Channel
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →